Related Experiment Video
Updated: Jul 16, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton
1Yale University School of Medicine, 333 Cedar Street, P.O. Box 208044, New Haven, CT 06520-8044, USA. roland.baron@yale.edu
Abstract:
The recent identification of a link between bone mass in humans and gain- or loss-of-function mutations in the Wnt coreceptor low-density lipoprotein receptor-related protein 5 (osteoporosis pseudoglioma syndrome, high bone mass trait) or in the Wnt antagonist sclerostin (sclerosteosis, van Buchem syndrome) has called the attention of academic and industry scientists and clinicians to the importance of this signaling pathway in skeletal biology and disease. Multiple genetic and pharmacological manipulations of Wnt signaling in mice have since then confirmed the central role of this pathway in regulating bone formation.
Insights
The Wnt signaling pathway is crucial for bone formation. Genetic studies in humans and mice reveal that mutations affecting Wnt signaling components like low-density lipoprotein receptor-related protein 5 and sclerostin directly impact bone mass and skeletal diseases.
Area of Science:
- Skeletal Biology
- Molecular Signaling
- Genetics
Background:
- The Wnt signaling pathway plays a critical role in skeletal development and homeostasis.
- Genetic variations in Wnt pathway components are linked to human bone mass disorders.
Purpose of the Study:
- To highlight the significance of the Wnt signaling pathway in skeletal biology and disease.
- To underscore the importance of Wnt pathway regulators in bone formation.
Main Methods:
- Review of genetic studies identifying mutations in Wnt pathway genes.
- Examination of Wnt signaling manipulation in mouse models.
Main Results:
- Gain- or loss-of-function mutations in low-density lipoprotein receptor-related protein 5 (LRP5) are associated with osteoporosis pseudoglioma syndrome and high bone mass.
- Mutations in sclerostin (SOST) are linked to sclerosteosis and van Buchem syndrome, affecting bone density.
- Studies in mice confirm Wnt signaling's central role in regulating bone formation.
Conclusions:
- The Wnt signaling pathway is a key regulator of bone mass.
- Targeting the Wnt pathway holds therapeutic potential for skeletal diseases.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Bone Remodeling